IDNA vs. MDEV
IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) and MDEV (First Trust Indxx Medical Devices ETF) are both Health & Biotech Equities funds - IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index while MDEV tracks the Indxx Global Medical Equipment Index. Both are passively managed. Over the past 3 years, IDNA returned 8.39%/yr vs -2.19%/yr for MDEV. A 0.64 correlation means they provide meaningful diversification when combined. IDNA charges 0.47%/yr vs 0.70%/yr for MDEV.
Performance
IDNA vs. MDEV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDNA achieves a 14.39% return, which is significantly higher than MDEV's -9.68% return.
IDNA
- 1D
- 3.70%
- 1M
- 1.49%
- YTD
- 14.39%
- 6M
- 11.58%
- 1Y
- 45.52%
- 3Y*
- 8.39%
- 5Y*
- -7.75%
- 10Y*
- —
MDEV
- 1D
- 2.04%
- 1M
- 3.02%
- YTD
- -9.68%
- 6M
- -10.44%
- 1Y
- -5.82%
- 3Y*
- -2.19%
- 5Y*
- —
- 10Y*
- —
IDNA vs. MDEV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 14.39% | 17.26% | -0.72% | -7.63% | -42.28% | -10.15% |
MDEV First Trust Indxx Medical Devices ETF | -9.68% | 2.00% | 1.79% | 7.55% | -28.59% | 4.16% |
Correlation
The correlation between IDNA and MDEV is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.56 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.58 |
Correlation (All Time) Calculated using the full available price history since Jun 24, 2021 | 0.64 |
The correlation between IDNA and MDEV has been stable across timeframes, ranging from 0.56 to 0.64 - a consistent structural relationship.
IDNA vs. MDEV - Sectors Allocation Comparison
Sectors
IDNA
MDEV
Healthcare
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IDNA
MDEV
Industrials
IDNA
MDEV
-
Basic Materials
IDNA
-
MDEV
-
Communication Services
IDNA
-
MDEV
-
Consumer Cyclical
IDNA
-
MDEV
-
Consumer Defensive
IDNA
-
MDEV
-
Energy
IDNA
-
MDEV
-
Financial Services
IDNA
-
MDEV
-
Real Estate
IDNA
-
MDEV
-
Technology
IDNA
-
MDEV
-
Utilities
IDNA
-
MDEV
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDNA vs. MDEV — Risk / Return Rank
IDNA
MDEV
IDNA vs. MDEV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and First Trust Indxx Medical Devices ETF (MDEV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IDNA | MDEV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.21 | ||
| Sortino ratioReturn per unit of downside risk | +3.07 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 0.95 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 4.29 | -0.32 | +4.61 |
| Martin ratioReturn relative to average drawdown | 12.20 | -0.80 | +13.01 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IDNA | MDEV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.85 | -0.36 | +2.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.27 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | -0.30 | +0.42 |
Drawdowns
IDNA vs. MDEV - Drawdown Comparison
The maximum IDNA drawdown since its inception was -68.26%, which is greater than MDEV's maximum drawdown of -42.34%. Use the drawdown chart below to compare losses from any high point for IDNA and MDEV.
Loading charts...
Drawdown Indicators
| IDNA | MDEV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.26% | -42.34% | -25.92% |
Max Drawdown (1Y)Largest decline over 1 year | -10.66% | -18.13% | +7.47% |
Max Drawdown (3Y)Largest decline over 3 years | -29.73% | -22.50% | -7.23% |
Max Drawdown (5Y)Largest decline over 5 years | -68.26% | — | — |
Current DrawdownCurrent decline from peak | -43.60% | -32.41% | -11.19% |
Average DrawdownAverage peak-to-trough decline | -36.25% | -25.66% | -10.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.74% | 7.26% | -3.52% |
Volatility
IDNA vs. MDEV - Volatility Comparison
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a higher volatility of 8.09% compared to First Trust Indxx Medical Devices ETF (MDEV) at 4.98%. This indicates that IDNA's price experiences larger fluctuations and is considered to be riskier than MDEV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDNA | MDEV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.09% | 4.98% | +3.11% |
Volatility (6M)Calculated over the trailing 6-month period | 18.14% | 11.61% | +6.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.71% | 16.14% | +8.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.46% | 19.00% | +9.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.55% | 19.00% | +10.55% |
IDNA vs. MDEV - Expense Ratio Comparison
IDNA has a 0.47% expense ratio, which is lower than MDEV's 0.70% expense ratio.
Dividends
IDNA vs. MDEV - Dividend Comparison
IDNA's dividend yield for the trailing twelve months is around 1.03%, while MDEV has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.03% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
MDEV First Trust Indxx Medical Devices ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IDNA and MDEV have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (8.09%) compared to MDEV (4.98%). In terms of maximum drawdown, IDNA dropped -68.26% vs MDEV's -42.34%.
On 3-year performance, IDNA leads with 8.39% vs -2.19% for MDEV. On fees, IDNA is cheaper at 0.47% per year. On volatility, MDEV has been the lower-risk option at 4.98%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IDNA has performed better with a 8.39% return vs -2.19%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IDNA is cheaper with a 0.47% expense ratio, compared with 0.70% for MDEV.
IDNA has the higher dividend yield at 1.03%, compared with 0.00% for MDEV.
IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while MDEV tracks Indxx Global Medical Equipment Index. They also come from different issuers: iShares and First Trust. Their fees differ too: 0.47% for IDNA and 0.70% for MDEV.
IDNA currently has the higher Sharpe Ratio (1.85 vs -0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDNA and MDEV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer